CareDx, Inc.
For the period ended Mar 31, 2026. Filed Apr 28, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed Apr 28, 2026
CDNA$80.77-4.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(In thousands, except share data)
| March 31, 2026 | December 31, 2025 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $77,923 | $65,429 |
| Marketable securities | 109,253 | 111,779 |
| Accounts receivable | 44,585 | 42,628 |
| Inventory | 26,404 | 26,705 |
| Prepaid and other current assets | 11,230 | 10,591 |
| Total current assets | 269,395 | 257,132 |
| Property and equipment, net | 33,156 | 32,971 |
| Operating lease right-of-use assets | 21,206 | 22,760 |
| Marketable securities, non-current | 10,901 | 24,165 |
| Intangible assets, net | 32,102 | 31,960 |
| Goodwill | 40,336 | 40,336 |
| Restricted cash | 551 | 551 |
| Other assets | 3,415 | 3,353 |
| Total assets | $411,062 | $413,228 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $9,066 | $9,988 |
| Accrued compensation | 20,545 | 38,107 |
| Accrued and other liabilities | 49,542 | 41,754 |
| Total current liabilities | 79,153 | 89,849 |
| Deferred tax liability | 130 | 181 |
| Operating lease liabilities, less current portion | 17,837 | 19,679 |
| Other liabilities | 407 | 418 |
| Total liabilities | 97,527 | 110,127 |
| Commitments and contingencies (Note 8) | ||
| Stockholders’ equity: | ||
| Preferred stock: $0.001 par value; 10,000,000 shares authorized at March 31, 2026 and December 31, 2025; no shares issued and outstanding at March 31, 2026 and December 31, 2025 | — | — |
| Common stock: $0.001 par value; 100,000,000 shares authorized at March 31, 2026 and December 31, 2025; 51,274,651 and 50,916,644 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 51 | 50 |
| Additional paid-in capital | 1,052,306 | 1,043,925 |
| Accumulated other comprehensive loss | (6,272) | (5,515) |
| Accumulated deficit | (732,550) | (735,359) |
| Total stockholders’ equity | 313,535 | 303,101 |
| Total liabilities and stockholders’ equity | $411,062 | $413,228 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.